2026 Autumn Call
Supports research advancing understanding, diagnosis, and treatment of Down syndrome (Trisomy 21) across basic, translational, clinical, and epidemiological science.
Funder: Jerome Lejeune Foundation
Due Dates: July 6, 2026 (opening) | August 14, 2026 (deadline)
Funding Amounts: Pilot grants: €50,000 (up to 2 years) | Advanced grants: €80,000 (up to 2 years)
Summary: Supports fundamental, translational, clinical, and epidemiological research exclusively focused on Trisomy 21 (Down syndrome).
Key Information: Strict ethical restrictions: no use of embryonic/fetal tissue or material from abortion, IVF, or cloning.
Description
The Jerome Lejeune Foundation’s Autumn Call funds research projects dedicated exclusively to Trisomy 21 (Down syndrome). The program supports a broad range of research, including fundamental, translational, clinical, epidemiological, and neuropsychology studies. Eligible projects may address disease aetiology, pathogenesis, progression, diagnosis, therapy, rehabilitation, or the development of new techniques. The objective is to generate new knowledge and improve health outcomes for individuals with Down syndrome. Projects are selected based on scientific excellence, innovation, feasibility, and anticipated clinical impact.
